Delivery Order SPE2DB20D1100-SPE2DB24FB7Y8

Award Date 5/14/24
Potential Completion Date 6/5/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Lenvima 14 mg daily dose 60-count pharmaceutical products. The $19,821.90 firm fixed-price delivery order contract has an ultimate completion date of December 20, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,279.78 contract, which has a firm fixed price pricing type, is for the supply of the drug Lenvima 14 mg in 60-count doses. The contract has an ultimate completion date of February 14, 2024 and was awarded on January 24, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $15,485.41 for the supply of LENVIMA 10 MG DAILY DOSE 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 19, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $19,821.90, is for the delivery of Lenvima 14 mg daily dose 60s. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $9,279.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563572600 ! LENVIMA 8 MG DAILY DOSE 60S. This order has a completion date of February 28, 2024 and was awarded on February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,910.95, is for the provision of LENVIMA 14 MG DAILY DOSE 60S, a pharmaceutical product. The contract is a firm-fixed-price delivery order contract with a period of performance through March 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The $9,279.78 firm fixed price delivery order is for the supply of the pharmaceutical product LENVIMA 14 MG DAILY DOSE 60S. The award has an ultimate completion date of April 24, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,159.74 firm-fixed-price contract is for the supply of Lenvima 14 mg daily dose 60s, a specialty medication. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,910.95 fixed-price delivery order is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025 and was awarded on March 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $9,579.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of LENVIMA 14 MG DAILY DOSE 60S, a pharmaceutical product. This delivery order contract has a firm fixed price and no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, such as the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB7Y8
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $18,559.58. The contract is for the supply of the pharmaceutical product Lenvima 14 mg daily dose, with a completion date of June 5, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment programs and facilities worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The current delivery order was awarded on a full and open competition basis without any set-aside designation.

Generated 8/13/24, 11:31 AM